Emmaus Life Sciences, Inc. SEC filings EMMA

Emmaus Life Sciences, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 2, 2009. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Dec 30, 2021 —
424B5 Prospectus supplement Mar 3, 2020 —
424B5 Prospectus supplement Oct 25, 2019 —
S-8 Employee stock plan registration Sep 12, 2019 —
424B3 Prospectus Jun 14, 2019 —
S-4/A Amendment no. 2 to s-4 Jun 11, 2019 —
S-4/A Amendment no. 1 to registration statement Jun 10, 2019 —
424B5 Prospectus supplement May 24, 2019 —
S-4 Registration for a merger or exchange Feb 13, 2019 —
424B3 Prospectus Dec 26, 2018 —
S-8 Employee stock plan registration Dec 14, 2018 —
S-1 Registration statement Dec 14, 2018 —
424B3 Prospectus Jun 8, 2018 —
S-3/A Filing Jun 8, 2018 —
S-3 Shelf registration May 22, 2018 —
S-1 Registration statement May 18, 2018 —
S-8 Employee stock plan registration May 18, 2018 —
S-3/A Filing May 18, 2018 —
S-3 Shelf registration Feb 23, 2018 —
S-3 Shelf registration Feb 23, 2018 —
424B4 Prospectus Jul 17, 2017 —
FWP Free writing prospectus Jul 13, 2017 —
S-1/A Amended registration statement Jul 13, 2017 —
FWP Free writing prospectus Jul 3, 2017 —
S-1/A Amended registration statement Jun 30, 2017 —
FWP Free writing prospectus Jun 19, 2017 —
S-1/A Amended registration statement Jun 16, 2017 —
S-1/A Amended registration statement Jun 2, 2017 —
S-1 Registration statement Mar 31, 2017 —
424B3 Prospectus Feb 16, 2017 —
S-8 Employee stock plan registration Jan 5, 2017 —
S-1 Registration statement Dec 30, 2016 —
S-1 Registration statement Dec 23, 2016 —
S-1/A Amended registration statement Jun 20, 2012 —
S-1/A Amended registration statement Jun 18, 2012 —
S-1/A Amended registration statement May 31, 2012 —
S-1/A Amended registration statement May 22, 2012 —
S-1/A Amended registration statement Apr 25, 2012 —
S-1/A Amended registration statement Apr 9, 2012 —
S-1/A Amended registration statement Jan 17, 2012 —
S-1/A Amended registration statement Jun 20, 2011 —
S-1 Registration statement May 5, 2011 —
424B3 Prospectus Apr 1, 2011 —
S-1/A Amended registration statement Mar 22, 2011 —
S-1/A Amended registration statement Jan 14, 2011 —
S-1/A Amended registration statement Nov 8, 2010 —
S-1/A Amended registration statement Sep 1, 2010 —
S-1/A Amended registration statement Jul 6, 2010 —
S-8 Employee stock plan registration Apr 29, 2010 —
S-1 Registration statement Feb 1, 2010 —

Showing 50 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EMMA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Torrance, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
822370
Former names
MYnd Analytics, Inc. (until Jul 12, 2019); CNS RESPONSE, INC. (until Dec 10, 2015); STRATIVATION, INC. (until Mar 1, 2007); SalesTactix, Inc. (until Aug 23, 2005); AGE RESEARCH INC (until Aug 5, 2004)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.